These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 7824044)

  • 1. Studies on the pharmacological interventions to prevent oxygen free radical (OFR)-mediated toxicity; effects of dopexamine, a DA1 receptor and beta 2 adrenoceptor agonist.
    Jacinto SM; Lokhandwala MF; Jandhyala BS
    Naunyn Schmiedebergs Arch Pharmacol; 1994 Sep; 350(3):277-83. PubMed ID: 7824044
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy and mechanisms of dopexamine in the prevention of ischemia-reperfusion induced organ damage: role of oxygen free radicals.
    Jacinto SM; Chintala MS; Lokhandwala MF; Jandhyala BS
    Clin Exp Hypertens; 1997; 19(1-2):181-90. PubMed ID: 9028645
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Salutary effects of dopexamine, a DA-1 and beta-2 agonist, on free radical-induced toxicity in anesthetized rats.
    Jacinto SM; Jandhyala BS
    Ann N Y Acad Sci; 1994 Jun; 723():349-52. PubMed ID: 7913299
    [No Abstract]   [Full Text] [Related]  

  • 4. Effect of pharmacological interventions in the prevention of lipid peroxidation and respiratory depression induced by oxygen free radicals in anesthetized rats.
    Jacinto SM; Lokhandwala MF; Jandhyala BS
    Free Radic Biol Med; 1996; 21(6):791-9. PubMed ID: 8902525
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential effects of clonidine, dopamine, dobutamine, and dopexamine on basal and acid-stimulated mucosal blood flow in the rat stomach.
    Holzer P; Painsipp E
    Crit Care Med; 2001 Feb; 29(2):335-43. PubMed ID: 11246314
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of the effects of dopexamine, a novel DA1 receptor and beta 2-adrenoceptor agonist, on cardiac function and splanchnic circulation in a canine model of hemorrhagic shock.
    Chintala MS; Moore RJ; Lokhandwala MF; Jandhyala BS
    Naunyn Schmiedebergs Arch Pharmacol; 1993 Mar; 347(3):296-300. PubMed ID: 8097568
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanisms mediating the positive inotropic and chronotropic changes induced by dopexamine in the anesthetized dog.
    Bass AS; Kohli JD; Lubbers N; Goldberg LI
    J Pharmacol Exp Ther; 1987 Sep; 242(3):940-4. PubMed ID: 2888876
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Dopexamine: a new dopaminergic agonist].
    Perrin G; Papazian L; Martin C
    Ann Fr Anesth Reanim; 1993; 12(3):308-20. PubMed ID: 7902685
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of chronic intravenous infusions of dopexamine and isoprenaline to rats on D1-, beta 1- and beta 2-receptor-mediated responses.
    Martin SW; Broadley KJ
    Br J Pharmacol; 1994 Jun; 112(2):595-603. PubMed ID: 7915614
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Renal vasodilatation by dopexamine and fenoldopam due to alpha 1-adrenoceptor blockade.
    Martin SW; Broadley KJ
    Br J Pharmacol; 1995 May; 115(2):349-55. PubMed ID: 7670737
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The cardiovascular actions of dopexamine hydrochloride, an agonist at dopamine receptors and beta 2-adrenoceptors in the dog.
    Smith GW; Hall JC; Farmer JB; Simpson WT
    J Pharm Pharmacol; 1987 Aug; 39(8):636-41. PubMed ID: 2888855
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Arrhythmogenic potential of dopexamine hydrochloride during halothane anaesthesia in dogs.
    Neustein SM; Dimich I; Sampson I; Sadeghi A; Mezrow C; Shiang H
    Can J Anaesth; 1994 Jun; 41(6):542-6. PubMed ID: 7915210
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of the effects of felodipine, verapamil and hydralazine on the survival rate of rats subjected to lethal effects of oxygen free radicals.
    Jacinto SM; Jandhyala BS
    Naunyn Schmiedebergs Arch Pharmacol; 1992 Oct; 346(4):457-61. PubMed ID: 1436130
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Contrasting effects of dopexamine hydrochloride on electrolyte excretion in canine kidney.
    Bass AS
    J Pharmacol Exp Ther; 1990 May; 253(2):798-802. PubMed ID: 1971021
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relative significance of dopamine receptors, beta adrenoceptors and norepinephrine uptake inhibition in the cardiovascular actions of dopexamine hydrochloride.
    Goldberg LI; Bass AS
    Am J Cardiol; 1988 Aug; 62(5):37C-40C. PubMed ID: 2841837
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [New dopamine agonists in cardiovascular therapy].
    Girbes AR; Van Veldhuisen DJ; Smit AJ
    Presse Med; 1992 Aug 29-Sep 5; 21(27):1287-91. PubMed ID: 1359528
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relative efficacy and potency of beta-adrenoceptor agonists for generating cAMP in human lymphocytes.
    MacGregor DA; Prielipp RC; Butterworth JF; James RL; Royster RL
    Chest; 1996 Jan; 109(1):194-200. PubMed ID: 8549185
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An introduction to the pharmacologic properties of Dopacard (dopexamine hydrochloride).
    Smith GW; O'Connor SE
    Am J Cardiol; 1988 Aug; 62(5):9C-17C. PubMed ID: 2900602
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dopexamine: a novel agonist at peripheral dopamine receptors and beta 2-adrenoceptors.
    Brown RA; Dixon J; Farmer JB; Hall JC; Humphries RG; Ince F; O'Connor SE; Simpson WT; Smith GW
    Br J Pharmacol; 1985 Jul; 85(3):599-608. PubMed ID: 2862944
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anatomical localization of the binding and functional characterization of responses to dopexamine hydrochloride in the rat mesenteric vasculature.
    Amenta F; Ricci A; Napoleone P; Vyas SJ; Lokhandwala MF
    Pharmacology; 1991; 42(4):211-22. PubMed ID: 1677201
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.